Cargando…
A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
BACKGROUND: There is an urgent need for more novel and efficacious therapeutic agents and strategies for the treatment of ovarian cancer - one of the most formidable female malignancies. These approaches should be based on comprehensive understanding of the pathobiology of this cancer and focused on...
Autores principales: | Kiselev, Vsevolod I., Ashrafyan, Levon A., Muyzhnek, Ekaterina L., Gerfanova, Evgeniya V., Antonova, Irina B., Aleshikova, Olga I., Sarkar, Fazlul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148762/ https://www.ncbi.nlm.nih.gov/pubmed/30236079 http://dx.doi.org/10.1186/s12885-018-4792-9 |
Ejemplares similares
-
Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane’s efficacy and safety in the treatment of CIN: implications for cervical cancer prevention
por: Ashrafian, Levon, et al.
Publicado: (2015) -
Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness
por: Shnaider, Polina V., et al.
Publicado: (2023) -
First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)
por: Paltsev, Mikhail, et al.
Publicado: (2016) -
Comparative preclinical pharmacokinetics study of 3,3′-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?
por: Paltsev, Mikhail, et al.
Publicado: (2013) -
Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)
por: Paltsev, Mikhail, et al.
Publicado: (2014)